Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission or other tangible benefit. Optum Store, Optum Perks, and Healthline ...

EVgo stock surges after the company receives a $1 billion Energy Department loan commitment, Levi Strauss tumbles after ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...

A representative at Hims states, “the online questionnaire is free and quite brief on the company website, and after the information is submitted, a healthcare provider will assess your ...

Hims & Hers Health plans to sell compounded ... according to the company’s website. Most U.S. patients are covered by health insurance and would likely pay less for the drugs.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

For patients on a 12-month plan, Hims offers a semaglutide injection for $199 a month, according to its website. The news comes after U.S. Senator Bernie Sanders said multiple generic drugmakers ...